Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Filings indexed 1,226 across all filing types
Latest filing 2012-05-22 Director's Dealing
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2012-05-22 English
4 Filing
Director's Dealing
2012-05-22 English
4 Filing
Director's Dealing
2012-05-22 English
4 Filing
Director's Dealing
2012-05-22 English
4 Filing
Director's Dealing
2012-05-22 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes an 'Item 8.01 Other Events' section describing presentations of clinical study posters at a conference, and an 'Item 9.01 Financial Statements and Exhibits' section listing exhibits related to clinical studies. There is no financial data, earnings information, or management discussion. The document is not an annual or quarterly report, nor is it a transcript or proxy statement. It is a regulatory filing reporting a material event (clinical study presentations) and attaching exhibits. The document length is under 5,000 characters, and it serves as a current report rather than a full report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2012-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.